Telomerase activity and cell proliferation index in cholesteatoma

Acta Oto-Laryngologica

Volumn 125, Issue 7, 2005, Pages 707-712

  Lee, Seung Hwan ^a   Jang, Young Ho ^a   Tae, Kyung ^a   Park, Yong Wook ^a   Kang, Mi Jung ^a   Kim, Kyung Rae ^a   Park, Chul Won ^a  

^a Hanyang University   (South Korea)

Author keywords

Cellular hyperproliferation; Cholesteatoma; Telomerase

Indexed keywords

KI 67 ANTIGEN; TELOMERASE;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; AUDITORY OSSICLE; BONE DESTRUCTION; CELL PROLIFERATION; CHILD; CHOLESTEATOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME ACTIVITY; HEARING LOSS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MIDDLE EAR SURGERY; PRIORITY JOURNAL; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

ADOLESCENT; ADULT; AGED; CELL PROLIFERATION; CHILD; CHOLESTEATOMA, MIDDLE EAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; TELOMERASE;

EID: 22944451130     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480410024479     Document Type: Article

References (25)

1. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlation of telomerase activity level with human neuroblastoma outcome. Nature Med 1995;1:249-55.
2. Dalbagni G, Han W, Zhang ZF, Cordon-Cardo C, Saigo P, Fair WR, et al. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Clin Cancer Res 1997;3:1593-8.
3. Hiyama K, Kirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995;155:3711 5.
4. Holt SE, Wright WE, Shay JW. Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 1996;95:90-2.
5. Min WS, Jung HS, Park JY, Jun BH, Song GY. Immunohistochemical study on the expression of proliferative markers of the squamous epithelium of the cholesteatoma. Korean J Otolaryngol 1995;38:1884-92.
6. Tanaka Y, Shima M, Kojima H, Miyazaki H, Kamide Y, Moriyama H. A study on epithelial proliferation ability in cholesteatoma. Laryngoscope 1998;108:537-41.
7. Blackburn EH. Structure and function of telomerase. Nature 1991;350:569-73.
8. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with aging. Mol Cell Biol 1989; 9:345-8.
9. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997;33:787-91.
10. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266: 2011-5.
11. Wright W, Piatyszek K, Rainey W, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 1996;18:173-9.
12. Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci U S A 1996;93:6476-81.
13. Kannan S, Tahara H, Yokozaki H, Mathew B, Nalinakumari KR, Nair MK, et al. Telomerase activity in premalignant and malignant lesions of human oral mucosa. Cancer Epiderm Biomarkers Prev 1997;6:413-20.
14. Tae K, Ahn MJ, Lee HS, Park BJ, Ahn KS. Telomerase activity in oral leukoplakia tissues. Korean J Otolaryngol 1999;42:82-7.
15. Kyo S, Takakura M, Kohoma T, Inoue M. Telomerase activity in human endometrium. Cancer Res 1997;57:610-4.
16. Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, Shay JW. Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol 1996;106:759-65.
17. Albino AP, Kimmelman CP, Parisier SC. Cholesteatoma: a molecular and cellular puzzle. Am J Otol 1998;19:7-19.
18. Bernal Sprekelsen M, Ebmeyer J, Buchbinder A, Sudhoff H. Comparative analysis of the proliferative capacity of cholesteatomas. Acta Otorrinolaringol Esp 2000;51:299-307.
19. Watabe-Rudolph M, Rudolph KL, Averbeck T, Buhr T, Lenarz T, Stover T. Telomerase activity, telomere length, and apoptosis: a comparison between acquired cholesteatoma and squamous cell carcinoma. Otol Neurotol 2002;23: 793-8.
20. Goh E, Lee B, Wang S, Chon K, Kim C. Expression of telomerase activity in cholesteatoma otitis media. J Laryngol Otol 2001;115:881-4.
21. Kojima H, Miyazaki H, Shiwa M, Tanaka Y, Moriyama H. Molecular biological diagnosis of congenital and acquired cholesteatoma on the basis of differences in telomere length. Laryngoscope 2001;111:867-73.
22. Kojima H, Tanaka Y, Tanaka T, Miyazaki H, Shiwa M, Kamide Y, et al. Cell proliferation and apoptosis in human middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg 1998;124:261-4.
23. Chae SW, Song JJ, Suh HK, Jung HH, Lim HH, Hwang SJ. Expression patterns of p27 and Ki-67 in cholesteatoma epithelium. Laryngoscope 2000;10:1898-901.
24. Ogoshi M, Le T, Shay JW, Taylor RS. In situ hybridization analysis of the expression of human telomerase RNA in normal and pathologic conditions of the skin. J Invest Dermatol 1998;110:818-23.
25. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.